An expected delay in a key step in CK Hutchison's planned sale of its Panama ports to a U.S. group, a deal blasted by Chinese ...

Biopharma leaders react to the forced resignation of CDER Head Peter Marks as RFK Jr.’s promised job cuts begin at the FDA; ...

The effect of glucagon-like peptide 1 receptor agonists on patients with joint infections was a popular topic at the American ...

The most well known GLP-1 medication is Ozempic, though in Australia it is only approved for the management of Type 2 ...

Dilip Shanghvi is not one for flamboyant statements or headline-grabbing moves. Yet, over the decades, the soft-spoken ...

State agency warns that new higher out-of-pocket prices will affect patients and pharmacies, increasing the risk of low-income patients being unable to afford long-term medication.

A recent study from the University of Pennsylvania has shown that the injectable drug semaglutide can help people lose a ...

For patients with symptomatic peripheral artery disease and type 2 diabetes, semaglutide use is associated with increased ...

The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain ...

A survey reveals that older adults strongly support Medicare coverage for weight management medications, but few are willing ...

Probiotics and turmeric are dietary supplements used for many health conditions. When taken together, they may improve gut ...